Boubacar Traore Selected Research

Boubacar Traore Research Topics

Disease

55	Malaria 04/2024 - 03/2002
26	Infections 04/2024 - 03/2002
4	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2022 - 07/2002
4	Acute malaria 01/2021 - 12/2011
3	Human Influenza (Influenza) 01/2022 - 01/2015
2	Sickle Cell Trait 04/2020 - 12/2011
2	Asymptomatic Infections 10/2016 - 04/2014
2	Cerebral Malaria 09/2004 - 03/2002
1	Epilepsy (Aura) 05/2024
1	Hypoxia (Hypoxemia) 04/2024
1	Inflammation (Inflammations) 04/2024
1	Headache (Headaches) 11/2022
1	Body Weight (Weight, Body) 11/2022
1	Coinfection 08/2022
1	Bites and Stings (Sting) 01/2021
1	Neoplasms (Cancer) 01/2020
1	Fever (Fevers) 10/2019
1	Parasitemia 10/2019
1	Communicable Diseases (Infectious Diseases) 11/2016
1	Acute Disease 11/2016
1	Persistent Infection 05/2015
1	Measles 01/2015
1	Hepatitis B 01/2015
1	Tetanus 01/2015

Drug/Important Bio-Agent (IBA)

19	AntibodiesIBA 01/2023 - 12/2009
14	Immunoglobulin G (IgG)IBA 11/2023 - 12/2011
11	CytokinesIBA 01/2021 - 09/2004
8	VaccinesIBA 01/2023 - 12/2009
8	AntigensIBA 08/2022 - 01/2011
7	Malaria VaccinesIBA 01/2021 - 11/2008
4	Monoclonal AntibodiesIBA 04/2024 - 08/2002
4	ChemokinesIBA 01/2021 - 04/2012
3	Immunoglobulin M (IgM)IBA 01/2021 - 04/2012
3	InterferonsIBA 10/2019 - 04/2012
3	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2014 - 07/2002
3	LigandsIBA 12/2011 - 03/2002
2	Immunoglobulin A (IgA)IBA 01/2023 - 01/2021
2	Sickle HemoglobinIBA 01/2023 - 11/2008
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 04/2014
2	hemoglobin AAIBA 01/2021 - 04/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2014
2	Immunoglobulins (Immunoglobulin)IBA 09/2015 - 04/2012
2	Chloroquine (Aralen)FDA LinkGeneric 01/2009 - 07/2002
1	HypoxanthineIBA 04/2024
1	PseudouridineIBA 04/2024
1	MucinsIBA 04/2024
1	CIS43LSIBA 11/2022
1	A-Form DNA (A-DNA)IBA 08/2022
1	Hemagglutinins (Hemagglutinin)IBA 01/2022
1	staphylococcal enterotoxin BIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 12/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Fc Receptors (Fc Receptor)IBA 10/2019
1	Transcription Factors (Transcription Factor)IBA 09/2017
1	2- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA 01/2017
1	OX40 ReceptorsIBA 05/2015
1	Polysaccharides (Glycans)IBA 12/2014
1	GalactosyltransferasesIBA 12/2014
1	Uridine Diphosphate Galactose (UDP Galactose)IBA 12/2014
1	Interleukin-8 (Interleukin 8)IBA 04/2014
1	Carrier Proteins (Binding Protein)IBA 03/2014
1	Programmed Cell Death 1 ReceptorIBA 12/2011
1	Hemoglobins (Hemoglobin)IBA 12/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2011
1	ProteomeIBA 04/2010
1	L 685458IBA 03/2009
1	Antimalarials (Antimalarial Agents)IBA 03/2009
1	signal peptide peptidaseIBA 03/2009
1	artemisinin (artemisinine)IBA 01/2009
1	Amodiaquine (Camoquin)FDA Link 01/2009
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2009
1	ArtesunateIBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004
1	IgE Receptors (Fc epsilon RI)IBA 09/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2004
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 08/2002
1	EpitopesIBA 08/2002
1	Immunoglobulin E (IgE)IBA 03/2002
1	NitrogenIBA 03/2002

Therapy/Procedure

5	Therapeutics 04/2024 - 01/2009
1	Polypharmacy 05/2024
1	Mass Drug Administration 01/2017
1	Aftercare (After-Treatment) 04/2014